Related Experiment Video
Updated: Jan 6, 2026

06:36
Nerve Stimulator-guided Injection of Autologous Stem Cells Near the Equine Left Recurrent Laryngeal Nerve
Published on: September 26, 2018
9.3K
In-Human Demonstration of High-Frequency Reversible Electrical Motor Nerve Block Compared to Selective Neurectomy-A
Rafal Szylak1, Michael Pridgeon2, Andrew Marshall
1From the Department of Neurosurgery, The Walton Centre NHS Foundation Trust, Liverpool, United Kingdom.
American Journal of Physical Medicine & Rehabilitation
|October 13, 2025
Summary
High-frequency nerve conduction block (HFNB) successfully replicated selective neurectomy effects in a human proof-of-concept study. This reversible electrical nerve block shows promise for treating spasticity.
Area of Science:
- Neurology
- Neurosurgery
- Biomedical Engineering
Background:
- Selective neurectomy is a surgical treatment for spasticity.
- High-frequency nerve conduction block (HFNB) offers a potential non-invasive alternative.
- This study aimed to validate HFNB's efficacy in humans.
Purpose of the Study:
- To test the feasibility of replicating selective neurectomy effects using HFNB.
- To evaluate the reversibility and comparability of HFNB to neurectomy.
- To assess HFNB as a potential treatment for spasticity.
Main Methods:
- In four participants undergoing tibial neurectomy for spasticity, HFNB was applied using a 10 kHz stimulation with an 8-contact electrode.
- Continuous EMG recorded nerve block and proximal stimulation effects.
- Reversibility was assessed by stopping stimulation; neurectomy effects were compared to HFNB.
Main Results:
- HFNB successfully induced a graded partial to complete nerve block in all participants.
- The block was fully reversible upon cessation of stimulation.
- EMG recordings post-neurectomy were comparable to those achieved with HFNB.
Conclusions:
- This study demonstrates the feasibility of a reversible electrical nerve block in humans.
- HFNB shows potential as a method to achieve motor block for spasticity treatment.
- This represents a significant step towards clinical application of HFNB for spasticity.

